[144] Insulet Corporation SEC Filing

Rhea-AI Filing Summary

Insulet Corporation (PODD) Form 144 reports a proposed sale of 4,263 shares of common stock through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $1,416,296.49 and an approximate sale date of 08/21/2025. The filing shows the shares to be sold were recently acquired by the seller through restricted stock vesting on 02/14/2025 (2,842 shares), 02/27/2025 (806 shares), and 02/28/2025 (615 shares), with consideration recorded as compensation. No securities were reported sold by the same person in the prior three months. The filer attests they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Acquisitions were via restricted stock vesting, indicating the holdings originated from compensation rather than open-market purchases
• No securities sold in the prior three months, which suggests this transaction is not part of a frequent disposal pattern

Negative

• Planned sale totals $1,416,296.49, representing a sizable insider liquidity event that investors may note
• Sale of recently vested shares could be interpreted as converting compensation into cash rather than long-term holding

Insights

Securities Analyst

TL;DR Insider plans to sell newly vested shares worth ~$1.42M; no prior sales in three months, routine disclosure under Rule 144.

The filing documents a Rule 144 notice for an insider sale of 4,263 common shares valued at $1,416,296.49 via Fidelity on NASDAQ with an approximate sale date of 08/21/2025. The underlying shares were acquired through restricted stock vesting in February 2025 and were paid as compensation. The absence of sales in the prior three months reduces the appearance of a pattern of disposals, but the planned sale is a meaningful one-time liquidity event for the holder. This is a standard compliance filing and does not, by itself, disclose material company developments.

Corporate Governance Expert

TL;DR Routine insider disclosure showing vested compensation being sold; consistent with standard governance and disclosure requirements.

The Form 144 provides required notice of a proposed sale under Rule 144. It identifies the broker, the number of shares, aggregate market value, and acquisition details showing vesting as the source. The signer affirms no undisclosed material information. From a governance perspective, this meets regulatory transparency expectations for insider transactions but does not indicate any governance-event or policy change.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4263	1416296.49	70392535	08/21/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2025	Restricted Stock Vesting	Issuer			2842	02/14/2025	Compensation
Common	02/27/2025	Restricted Stock Vesting	Issuer			806	02/27/2025	Compensation
Common	02/28/2025	Restricted Stock Vesting	Issuer			615	02/28/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Insulet Corporation's (PODD) Form 144 report?

The filing notifies a proposed sale of 4,263 common shares valued at $1,416,296.49 through Fidelity on NASDAQ with an approximate sale date of 08/21/2025.

How were the shares being sold acquired according to the Form 144?

The shares were acquired through restricted stock vesting on 02/14/2025 (2,842 shares), 02/27/2025 (806 shares), and 02/28/2025 (615 shares), and were recorded as compensation.

Did the filer sell any Insulet (PODD) shares in the prior three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker is handling the proposed sale in the Form 144?

The broker named in the filing is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI, and the exchange listed is NASDAQ.

Does the filer attest to having undisclosed material information?

Yes. The person for whose account the sale is proposed represents they do not know any material adverse information about the issuer that has not been publicly disclosed.